182 related articles for article (PubMed ID: 15855175)
41. [Acute cardiotoxicity from 5-fluorouracil: un underestimated toxicity].
Bertolini A; Fiumanò M; Muffatti A; Pedroncelli S; Doria A; Codazzi G; Giustiniani S; Scarinci A; Redaelli G
Minerva Cardioangiol; 1999; 47(7-8):269-73. PubMed ID: 10582438
[TBL] [Abstract][Full Text] [Related]
42. [Cardiotoxicity of 5-fluorouracil: report of 6 cases].
Timour Q; Lombard-Bohas C; Slim R; Barel C; Bui-Xuan B; Tabib A; Bricca G; Malonne H; Vial T; Iordescu D; Descotes J
Therapie; 2002; 57(3):302-6. PubMed ID: 12422546
[TBL] [Abstract][Full Text] [Related]
43. Fluoropyrimidine-associated cardiotoxicity: revisited.
Saif MW; Shah MM; Shah AR
Expert Opin Drug Saf; 2009 Mar; 8(2):191-202. PubMed ID: 19309247
[TBL] [Abstract][Full Text] [Related]
44. [5-fluorouracil: cause of a fatal myocardial infarction in combined radiochemotherapy?].
Maurer U; Härle M; Jungius KP
Strahlenther Onkol; 1996 May; 172(5):257-9. PubMed ID: 8633257
[TBL] [Abstract][Full Text] [Related]
45. [Cardiotoxicity of continuous intravenous infusion of 5-fluorouracil: clinical study, prevention and physiopathology. Apropos of 13 cases].
de Forni M; Bugat R; Sorbette F; Delay M; Bachaud JM; Chevreau C
Bull Cancer; 1990; 77(5):429-38. PubMed ID: 2205312
[TBL] [Abstract][Full Text] [Related]
46. A new perspective on cardiotoxicity of 5-fluorouracil. A novel research tool 'cardiac ultrasonic integrated backscatter analysis' indicates transient, subclinical myocardial dysfunction due to high-dose leucovorin and infusional 5-fluorouracil regimen.
Barutca S; Ceyhan C; Meydan N; Ozturk B; Tekten T; Onbasili A; Kadikoylu G; Bolaman Z
Chemotherapy; 2004 Jun; 50(3):113-8. PubMed ID: 15272225
[TBL] [Abstract][Full Text] [Related]
47. [Cardiac side effects of 5-fluorouracil].
May D; Wandl U; Becher R; Niederle N; Schmidt CG
Dtsch Med Wochenschr; 1990 Apr; 115(16):618-21. PubMed ID: 2328669
[TBL] [Abstract][Full Text] [Related]
48. [Cardiotoxicity of 5-fluorouracil. Apropos of a new case].
Escudier B; Conscience G; Nkam M; Leclercq B; Rougier P; Nitenberg G
Arch Mal Coeur Vaiss; 1985 Oct; 78(10):1579-81. PubMed ID: 3938225
[TBL] [Abstract][Full Text] [Related]
49. Ultrasound tissue characterization by integrated backscatter for analyzing Fluorouracil induced myocardial damage.
Ceyhan C; Meydan N; Barutca S; Tekten T; Onbasili AO; Ozturk B; Unal S
Echocardiography; 2005 Mar; 22(3):233-8. PubMed ID: 15725158
[TBL] [Abstract][Full Text] [Related]
50. [Cardiotoxicity of 5-fluorouracil. Spasm or direct myocardial toxicity?].
Thyss A; Falewee MN; Leborgne L; Viens P; Schneider M; Demard F
Bull Cancer; 1987; 74(4):381-5. PubMed ID: 3663962
[TBL] [Abstract][Full Text] [Related]
51. Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil.
Eskilsson J; Albertsson M
Acta Oncol; 1990; 29(8):1001-3. PubMed ID: 2278719
[TBL] [Abstract][Full Text] [Related]
52. Endothelin-1 and 5-fluorouracil-induced cardiotoxicity.
Porta C; Moroni M; Ferrari S; Nastasi G
Neoplasma; 1998; 45(2):81-2. PubMed ID: 9687887
[TBL] [Abstract][Full Text] [Related]
53. Symptomatic cardiotoxicity with high-dose 5-fluorouracil infusion: a prospective study.
Akhtar SS; Salim KP; Bano ZA
Oncology; 1993; 50(6):441-4. PubMed ID: 8233284
[TBL] [Abstract][Full Text] [Related]
54. Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study.
Peng J; Dong C; Wang C; Li W; Yu H; Zhang M; Zhao Q; Zhu B; Zhang J; Li W; Wang F; Wu Q; Zhou W; Yuan Y; Qiu M; Chen G
Cancer Commun (Lond); 2018 May; 38(1):22. PubMed ID: 29764506
[TBL] [Abstract][Full Text] [Related]
55. [Cardiotoxicity induced by 5-fluorouracil. Review of the literature].
Blázquez Encinar JC; Martín Jiménez M; Díaz-Rubio García E; Almenarez J
Rev Clin Esp; 1989 Mar; 184(5):249-51. PubMed ID: 2672149
[TBL] [Abstract][Full Text] [Related]
56. Acute severe coronary spasm associated with initial first dose of 5-fluorouracil chemotherapy.
Mariani G; Giaccon G; Mastore M
Ital Heart J; 2003 Aug; 4(8):568-70. PubMed ID: 14564986
[TBL] [Abstract][Full Text] [Related]
57. Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal.
Upshaw JN; O'Neill A; Carver JR; Dimond EP; Denlinger CS; Kircher SM; Wagner LI; Ky B; Brell JM
Clin Colorectal Cancer; 2019 Mar; 18(1):44-51. PubMed ID: 30348619
[TBL] [Abstract][Full Text] [Related]
58. [Cardiotoxicity of 5-fluorouracil. Clinical picture of 4 cases and a prevention proposal].
Bourgeois H; Perault MC; Raud-Raynier P; Favrelière S; Daban A; Vandel B
Therapie; 1993; 48(3):255-8. PubMed ID: 8140566
[TBL] [Abstract][Full Text] [Related]
59. Cardiotoxicity of 5-flourouracil: two case reports.
Tutkun A; Inanli S; Caymaz O; Ayanoğlu E; Duman D
Auris Nasus Larynx; 2001 Apr; 28(2):193-6. PubMed ID: 11240331
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of cardiotoxicity of a combined bolus plus infusional 5-fluorouracil/folinic acid treatment by echocardiography, plasma troponin I level, QT interval and dispersion in patients with gastrointestinal system cancers.
Oztop I; Gencer M; Okan T; Yaren A; Altekin E; Turker S; Yilmaz U
Jpn J Clin Oncol; 2004 May; 34(5):262-8. PubMed ID: 15231861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
